SWTX

SpringWorks Therapeutics, Inc.

41.60 USD
-0.71 (-1.68%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

SpringWorks Therapeutics, Inc. stock is down -10.44% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 2 PUTs, 8 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
29 Apr 16:07 17 Jan, 2025 50.00 PUT 99 0
30 Apr 14:05 17 Jan, 2025 50.00 PUT 200 228
01 May 18:19 17 May, 2024 50.00 CALL 331 56
01 May 18:35 21 Jun, 2024 50.00 CALL 77 2261
03 May 16:37 21 Jun, 2024 50.00 CALL 165 2338
08 May 14:31 21 Jun, 2024 50.00 CALL 342 2333
17 May 15:20 21 Jun, 2024 45.00 CALL 1000 100
28 May 19:28 19 Jul, 2024 35.00 CALL 35 0
28 May 19:33 19 Jul, 2024 35.00 CALL 54 0
28 May 19:36 19 Jul, 2024 35.00 CALL 74 0

About SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors.